[go: up one dir, main page]

MX2011007471A - Composicion que comprende acido chicorico y/o derivados del mismo. - Google Patents

Composicion que comprende acido chicorico y/o derivados del mismo.

Info

Publication number
MX2011007471A
MX2011007471A MX2011007471A MX2011007471A MX2011007471A MX 2011007471 A MX2011007471 A MX 2011007471A MX 2011007471 A MX2011007471 A MX 2011007471A MX 2011007471 A MX2011007471 A MX 2011007471A MX 2011007471 A MX2011007471 A MX 2011007471A
Authority
MX
Mexico
Prior art keywords
derivatives
composition
acid
chicoric acid
present
Prior art date
Application number
MX2011007471A
Other languages
English (en)
Inventor
Rachid Bel-Rhlid
Thomas Wolfgang Raab
Vanessa Crespy
Nicole Page-Zoerkler
Rene Fumeaux
Dominique Piguet
Maricel Marin-Kuan
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011007471A publication Critical patent/MX2011007471A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • C12P7/46Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/0102Tannase (3.1.1.20)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/151Johnsonii
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)

Abstract

La presente invención se refiere de manera general al campo de alimentos y bebidas. En particular, por ejemplo, se proporciona una composición que permite suministrar ácido tartárico y/o ácido caféico a un sujeto. Una modalidad de la presente invención es una composición que comprende un ingrediente que contiene ácido chicórico y/o derivados del mismo, y una bacteria de ácido láctico capaz de hidrolizar ácido chicórico y/o derivados del mismo para generar ácido tartárico y/o caféico.
MX2011007471A 2009-01-27 2010-01-27 Composicion que comprende acido chicorico y/o derivados del mismo. MX2011007471A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09151390A EP2210504A1 (en) 2009-01-27 2009-01-27 Composition comprising chicoric acid and/or derivatives thereof
PCT/EP2010/050914 WO2010086322A1 (en) 2009-01-27 2010-01-27 Composition comprising chicoric acid and/or derivatives thereof

Publications (1)

Publication Number Publication Date
MX2011007471A true MX2011007471A (es) 2011-08-03

Family

ID=40635768

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007471A MX2011007471A (es) 2009-01-27 2010-01-27 Composicion que comprende acido chicorico y/o derivados del mismo.

Country Status (14)

Country Link
US (1) US20110280848A1 (es)
EP (2) EP2210504A1 (es)
JP (1) JP2012515541A (es)
KR (1) KR20110119723A (es)
CN (1) CN102333455A (es)
AR (1) AR075188A1 (es)
AU (1) AU2010209797A1 (es)
BR (1) BRPI1007194A2 (es)
CA (1) CA2750685A1 (es)
CO (1) CO6400174A2 (es)
MX (1) MX2011007471A (es)
RU (1) RU2011135819A (es)
WO (1) WO2010086322A1 (es)
ZA (1) ZA201106300B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1917960A1 (en) * 2006-11-06 2008-05-07 Nestec S.A. Improved biological effects of rosmarinic acid
US9492365B2 (en) * 2010-06-30 2016-11-15 Nestec S.A. Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation
RU2012155852A (ru) 2010-06-30 2014-06-27 Нестек С.А. Применение цикориевой кислоты и её производных для регулирования пигментации кожи
KR101850166B1 (ko) 2010-06-30 2018-04-18 네스텍 소시에테아노님 피부 색소침착 조절용 식품 보충제에서의 치커리산 및 락틱 박테리아의 용도
JP6346091B2 (ja) * 2011-10-11 2018-06-20 イーエルシー マネージメント エルエルシー 皮膚を処理するための方法および組成物
CN104427989B (zh) 2012-06-22 2019-10-15 雀巢产品有限公司 抗神经变性的益生菌和多酚
WO2014165297A1 (en) * 2013-03-12 2014-10-09 HMI Medical Innovations, LLC Plant extracts with anti-diabetic and other useful activities
CN103408423A (zh) * 2013-07-17 2013-11-27 张家港威胜生物医药有限公司 一种天然活性产物l-菊苣酸的合成工艺
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US20210038491A1 (en) * 2018-03-23 2021-02-11 Morinaga Milk Industry Co., Ltd. Composition for Inactivating Smell Component
CN110786241B (zh) * 2019-11-28 2022-03-22 大连市现代农业生产发展服务中心(大连市农业科学研究院) 一种提高液体培养紫锥菊不定根中菊苣酸积累的培养方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU459273B2 (en) * 1971-05-17 1975-03-20 Sankyo Company Limited Process for making wines
FR2591073B1 (fr) * 1985-12-10 1988-02-19 Leroux Sarl Chicoree Boisson a base de chicoree et procede de preparation de ladite boisson
JP2003250528A (ja) * 2002-03-06 2003-09-09 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
EP1610623B1 (en) * 2003-03-25 2011-11-23 Aarhus Universitet Methodologies for improving the quality of meat, health status of animals and impact on environment
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2006026763A1 (en) * 2004-09-01 2006-03-09 Pioneer Hi-Bred International, Inc. Ferulate esterase producing strains and methods of using same
ES2542713T3 (es) * 2005-09-28 2015-08-10 Constellation Brands, Inc. Extracto de uva, suplemento en la dieta del mismo y procedimiento de preparación
NZ567332A (en) * 2005-09-28 2011-05-27 Univ California Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
WO2008028300A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
EP1917960A1 (en) * 2006-11-06 2008-05-07 Nestec S.A. Improved biological effects of rosmarinic acid
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
WO2008093670A1 (ja) * 2007-02-01 2008-08-07 Tk Bio-Research Laboratory Co., Ltd. ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品
EP1985191A1 (en) * 2007-04-27 2008-10-29 Universita'degli Studi Di Milano Preparation of polyfunctional fermented food products
CA2723109A1 (en) * 2008-04-30 2009-11-05 Nestec S.A. Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid
EP2300603A4 (en) * 2008-06-24 2011-08-03 Micropharma Ltd OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF SKIN DISEASES AND MICROBIAL INFECTIONS

Also Published As

Publication number Publication date
CO6400174A2 (es) 2012-03-15
RU2011135819A (ru) 2013-03-10
EP2391228A1 (en) 2011-12-07
US20110280848A1 (en) 2011-11-17
ZA201106300B (en) 2013-02-27
CN102333455A (zh) 2012-01-25
BRPI1007194A2 (pt) 2015-08-25
AU2010209797A1 (en) 2011-07-28
WO2010086322A1 (en) 2010-08-05
EP2210504A1 (en) 2010-07-28
AR075188A1 (es) 2011-03-16
CA2750685A1 (en) 2010-08-05
JP2012515541A (ja) 2012-07-12
KR20110119723A (ko) 2011-11-02

Similar Documents

Publication Publication Date Title
MX2011007472A (es) Composicion que comprende acido caftarico y/o derivados del mismo.
MX2011007471A (es) Composicion que comprende acido chicorico y/o derivados del mismo.
NZ595939A (en) Use of modified peptide gamma-glu-abu for imparting or enhancing food or beverage taste
EP2705140B8 (de) Neue milchsäurebakterien und diese enthaltende zusammensetzungen
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
ATE524984T1 (de) Haltbares probiotisches nahrungsmittelprodukt
MX336229B (es) Microorganismos y metodos para la biosintesis de butadieno.
MX2014004366A (es) Aceleracion de la recuperacion muscular despues de la atrofia muscular inducida por inmovilizacion.
MX2013011626A (es) Efecto antimicrobiano sinergico.
PL2753687T3 (pl) Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium
EP4104682A3 (en) Methods and compositions for affecting the flavour and aroma profile of consumables
IN2012DN01638A (es)
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
MX2015017994A (es) Metodos de conservacion biologica para bebidas y otros alimentos.
PH12013500851A1 (en) Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
MY172574A (en) Dicaffeoylquinic acid-containing drink
IN2012DN02283A (es)
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
EP2588070B8 (en) USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR lightening and/or whitening skin tone
MY155505A (en) Taste-improving agent for foods and drinks
JO2889B1 (en) Salts 6N - (CIS-2, 6-dimethyl morpholine-4-yl) pyridine-3-yl-methyl-4 ’- (tetrafluoromethoxy) [1,1,-2-phenyl] -3-carboxamide
IN2014MN01542A (es)
PH12013500761A1 (en) Cysteine and food intake
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
MX357911B (es) Peptido mejorador de sabor.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal